This certifies that the facility adheres to a comprehensive set of regulatory standards as set by the NABP to ensure safety of drugs and medical devices in the US.
The NABP Drug Distributor Accreditation is a resource for industry and regulatory bodies that establish uniform safeguards meant to protect the public health. This distinction plays a pivotal role in preventing counterfeit drugs from entering the United States drug supply and protects the public from drugs that have been contaminated, diverted, or counterfeited. This accreditation process required Hilco Vision to demonstrate compliance to a comprehensive set of regulatory standards and best practices in safely distributing prescription drugs from manufacturers to pharmacies and other institutions.
“It is more important than ever to strive for the highest standards of compliance in pharmaceutical distribution. This accreditation for our Nevada facility demonstrates our commitment to continuous improvement in supply chain on behalf of our customers,” says Ross Brownlee, CEO of Hilco Vision in the company’s news release.
NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh shared how this accreditation of Hilco’s Las Vegas facility is key to public health. In the press release, he said, “NABP congratulates Hilco Vision on achieving this important recognition. By earning the Drug Distributor Accreditation, they demonstrate their commitment to preventing counterfeit drugs from entering the US drug supply, and they hold a pivotal role in protecting the public health.”